Skip to main content

Advertisement

Log in

Allogeneic stem cell transplantation from related and unrelated donors for aplastic anaemia in adults—a single-centre experience

  • Original Article
  • Published:
Annals of Hematology Aims and scope Submit manuscript

Abstract

Aplastic anaemia (AA) is a rare bone marrow failure syndrome treated either by immunosuppressive therapy or allogeneic stem cell transplantation (SCT). At present, no randomised clinical trials evaluating both treatment options, and in particular SCT from unrelated donors, are available. We here report the clinical course and outcome of allogeneic SCT for 20 consecutive adult patients with AA. Newly diagnosed and untreated patients (n = 8) or patients pre-treated by immunosuppressive therapy (n = 12) were transplanted either from human-leukocyte-antigen (HLA) identical family donors (n = 13) or matched (n = 6) and mismatched (n = 1) unrelated donors, respectively. Conditioning varied depending on donor type and included cyclophosphamide with or without anti-thymocyte globulin (ATG) and fludarabine–cyclophosphamide–ATG with or without low-dose total body irradiation. With a median follow-up of more than 40 months, all patients have had favourable outcomes with stable haematopoietic engraftment and high performance scores. Six patients developed acute (five I°–II°; one >II°) and four limited chronic graft-versus-host disease. In this group of AA patients, allogeneic SCT has proven very successful, independent of donor type and pre-treatment. Studies with greater cohorts of patients are warranted to better determine indication and timing of SCT especially from unrelated donors in AA.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Young N, Calado R, Scheinberg P (2006) Current concepts in the pathophysiology and treatment of aplastic anemia. Blood 108(8):2509–2519

    Article  PubMed  CAS  Google Scholar 

  2. Marsh J, Ball S, Darbyshire P, Gordon-Smith E, Keidan A, Martin A et al. (2003) Guidelines for the diagnosis and management of acquired aplastic anaemia. Br J Haematol 123(5):782–801

    Article  PubMed  CAS  Google Scholar 

  3. Locasciulli A, Oneto R, Bacigalupo A, Socie G, Korthof E, Bekassy A et al. (2007) Outcome of patients with acquired aplastic anemia given first line bone marrow transplant or immunosuppressive treatment in the last decade: a report from the European Group for Blood and Marrow Transplantation (EBMT). Haematologica 92(1):11–8

    Article  PubMed  CAS  Google Scholar 

  4. Bai L, Chiou T, Liu JH, Yen CW, Yan M, Hsiao L et al. (2004) Hematopoietic stem cell transplantation for severe aplastic anemia—experience of an institute in Taiwan. Ann Hematol 83(1):38–43

    Article  PubMed  CAS  Google Scholar 

  5. Reiter E, Keil F, Brugger S, Kahls P, Rabitsch W, Hinterberger W et al. (1997) Excellent long-term survival after allogeneic marrow transplantation in patients with severe aplastic anemia. Bone Marrow Transplant 19(12):1191–1196

    Article  PubMed  CAS  Google Scholar 

  6. Bacigalupo A, Hows J, Gordon-Smith E, Gluckman E, Van Lint M, Congiu M et al. (1988) Bone marrow transplant for severe aplastic anemia from donors other than HLA identical siblings: a report of BMT Working Party. Bone Marrow Transplant 3(6):531–535

    PubMed  CAS  Google Scholar 

  7. Hows J, Szydlo R, Anasetti C, Camitta B, Gajewski J, Gluckman E (1992) Unrelated donor marrow transplants for severe acquired aplastic anemia. Bone Marrow Transplant 10(Suppl 1):102–106

    PubMed  Google Scholar 

  8. Kernan N, Bartsh G, Ash R, Beatty P, Champlin R, Filipovich A et al. (1993) Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. N Engl J Med 328(9):593–602

    Article  PubMed  CAS  Google Scholar 

  9. Margolis D, Casper J (2000) Alternative-donor hematopoietic stem-cell transplantation for severe aplastic anemia. Semin Hematol 37(1):43–55

    Article  PubMed  CAS  Google Scholar 

  10. Passweg J, Pérez W, Eapen M, Camitta B, Gluckman E, Hinterberger W et al. (2006) Bone marrow transplants from mismatched related and unrelated donors for severe aplastic anemia. Bone Marrow Transplant 37(7):641–649

    Article  PubMed  CAS  Google Scholar 

  11. Maury S, Balère-Appert ML, Chir Z, Boiron JM, Galambrun C, Yakouben K et al. (2007) Unrelated stem cell transplantation for severe acquired aplastic anemia: improved outcome in the era of high-resolution HLA matching between donor and recipient. Haematologica 92(5):589–596

    Article  PubMed  Google Scholar 

  12. Horowitz M (2000) Current status of allogeneic bone marrow transplant in acquired aplastic anemia. Semin Hematol 37(1):30–42

    Article  PubMed  CAS  Google Scholar 

  13. Deeg H, Seidel K, Casper J, Anasetti C, Davies S, Gajewski J et al. (1999) Marrow transplantation from unrelated donors for patients with severe aplastic anemia who have failed immunosuppressive therapy. Biol Blood and Marrow Transplantation 5(4):243–252

    Article  CAS  Google Scholar 

  14. Bacigalupo A, Locatelli F, Lanino E, Marsh J, Socié G, Maury S et al. (2005) Fludarabine, cyclophosphamide and anti-thymocyte globulin for alternative donor transplants in acquired severe aplastic anemia: a report from the EBMT-SAA Working Party. Bone Marrow Transplant 36(11):947–950

    Article  PubMed  CAS  Google Scholar 

  15. Deeg H, O'Donnell M, Tolar J, Agarwal R, Harris R, Feig S et al. (2006) Optimization of conditioning for marrow transplantation from unrelated donors for patients with aplastic anemia after failure of immunosuppressive therapy. Blood 108:1485–1491

    Article  PubMed  CAS  Google Scholar 

  16. Storb R, Blume K, O'Donnell M, Chauncey T, Forman S, Deeg H et al. (2001) Cyclophosphamide and antithymocyte globulin to condition patients with aplastic anemia for allogeneic marrow transplantations: the experience in four centers. Biol Blood and Marrow Transplantation 7(1):39–44

    Article  CAS  Google Scholar 

  17. Kahl C, Leisenring W, Deeg H, Chauncey T, Flowers M, Martin P et al. (2005) Cyclophosphamide and antithymocyte globulin as a conditioning regimen for allogeneic marrow transplantation in patients with aplastic anaemia: a long-term follow-up. Br J Haematol 130(5):747–751

    Article  PubMed  CAS  Google Scholar 

  18. Kojima S, Matsuyama T, Kato S, Kigasawa H, Kobayashi R, Kikuta A et al. (2002) Outcome of 154 patients with severe aplastic anemia who received transplants from unrelated donors: the Japan Marrow Donor Program. Blood 100(3):799–803

    Article  PubMed  CAS  Google Scholar 

  19. Kennedy-Nasser AA, Leung KS, Mahajan A, Weiss HL, Arce JA, Gottschalk S et al. (2006) Comparable outcomes of matched-related and alternative donor stem cell transplantation for pediatric severe aplastic anemia. Biol Blood Marrow Transplant 12:1277–1284

    Article  PubMed  Google Scholar 

  20. Inamoto Y, Suzuki R, Kuwatsuka Y, Yasuda T, Takahashi T, Tsujimura A et al. (2008) Long-term outcome after Bone Marrow Transplant for aplastic anemia using cyclophosphamide and total lymphoid irradiation as conditioning regimen. Biol Blood Marrow Transplant 14:43–49

    Article  PubMed  CAS  Google Scholar 

  21. Teramura M, Kimura A, Iwase S, Yonemura Y, Nakao S, Urabe A et al. (2007) Treatment of severe aplastic anemia with antithymocyte globulin and cyclosporin A with or without G-CSF in adults: a multicenter randomized study in Japan. Blood 110:1756–1761

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M. Eder.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Buchholz, S., Dammann, E., Koenecke, C. et al. Allogeneic stem cell transplantation from related and unrelated donors for aplastic anaemia in adults—a single-centre experience. Ann Hematol 87, 551–556 (2008). https://doi.org/10.1007/s00277-008-0466-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-008-0466-z

Keywords

Navigation